Liver retransplantation for hepatitis C: Seeing is believing

Liver Transplantation

Volumn 13, Issue 9, 2007, Pages 1217-1218

  Rosen, Hugo R ^a,b  

^a CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; PROTHROMBIN;

CLINICAL ASSESSMENT; EDITORIAL; GRAFT FAILURE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; INTERMETHOD COMPARISON; LIVER TRANSPLANTATION; MORTALITY; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE;

HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; MULTICENTER STUDIES; REGISTRIES; REOPERATION; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; UNITED STATES;

EID: 34648846187     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21191     Document Type: Editorial

References (6)

1. McCashland T, Watt K, Lyden F, Adams L, Charlton M, Smith AD, et al. Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. Liver Transpl 2007; 13:1246-1253.
2. Rosen HR, Martin P. Hepatitis C infection in patients undergoing liver retransplantation. Transplantation 1998;66: 1612-1616.
3. Pelletier SJ, Schaubel DE, Punch JD, Wolfe RA, Port FK, Merion RM. Hepatitis C is a risk factor for death after liver retransplantation. Liver Transpl 2005,11:434-440.
4. Burton JR, Jr, Rosen HR. Retransplantation for HCV: survey of practice patterns in the United States. Clin Gastroenterol Hepatol 2005;3:700-704.
5. Rosen HR, Prieto M, Casanovas-Taltavull T, Cuervas-Mons V, Guckelberger O, Muiesan P, et al. Validation and refinement of survival models for liver retransplantation. Hepatology 2003;38:460-469.
6. Zimmerman MA, Ghobrial RM. When shouldn't we retransplant? Liver Transpl 2005;11(Suppl 2):S14-S20.